Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-20 7:11 pm Purchase | 13D | INOZYME PHARMA INC INZY | Sofinnova Venture Partners X L.P. | 4,280,308 6.9% | 2,252,000 (+111.03%) | View |
| 2024-02-14 8:34 pm Sale | 13G | INOZYME PHARMA INC INZY | Venrock Healthcare Capital Partners II L.P. | 0 0% | -3,867,749 (Position Closed) | View |
| 2024-02-14 6:08 pm Sale | 13G | INOZYME PHARMA INC INZY | New Enterprise Associates 15 L.P. | 0 0% | -2,437,689 (Position Closed) | View |
| 2024-02-14 4:21 pm Sale | 13G | INOZYME PHARMA INC INZY | BAKER BROS. ADVISORS LP | 0 0% | -2,168,000 (Position Closed) | View |
| 2024-02-14 2:10 pm Purchase | 13G | INOZYME PHARMA INC INZY | Rock Springs Capital Management LP | 3,681,174 5.96% | 595,147 (+19.29%) | View |
| 2024-02-14 1:40 pm Purchase | 13G | INOZYME PHARMA INC INZY | SAMLYN CAPITAL LLC | 3,372,558 5.5% | 3,372,558 (New Position) | View |
| 2024-02-14 11:54 am Purchase | 13G | INOZYME PHARMA INC INZY | EVENTIDE ASSET MANAGEMENT LLC | 3,179,837 5.15% | 3,179,837 (New Position) | View |
| 2024-02-14 08:48 am Sale | 13G | INOZYME PHARMA INC INZY | Deep Track Capital LP | 0 0% | -3,250,000 (Position Closed) | View |
| 2024-02-12 9:06 pm Unchanged | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 4,494,851 7.2% | 0 (Unchanged) | View |
| 2024-02-07 07:46 am Purchase | 13G | INOZYME PHARMA INC INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.97% | 2,437,362 (+78.62%) | View |
| 2024-02-05 09:12 am Sale | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 1,562,907 2.53% | -533,351 (-25.44%) | View |
| 2024-01-16 4:12 pm Sale | 13G | INOZYME PHARMA INC INZY | MILLENNIUM MANAGEMENT LLC | 911,465 1.5% | -1,381,362 (-60.25%) | View |
| 2023-08-11 4:08 pm Purchase | 13D | INOZYME PHARMA INC INZY | Longitude Capital Partners III LLC | 5,841,045 9.9% | 1,666,666 (+39.93%) | View |
| 2023-08-07 9:58 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 4,494,851 9.5% | 833,333 (+22.76%) | View |
| 2023-05-31 4:17 pm Purchase | 13G | INOZYME PHARMA INC INZY | MILLENNIUM MANAGEMENT LLC | 2,292,827 5.2% | 2,292,827 (New Position) | View |
| 2023-05-23 4:48 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 3,661,518 8.3% | 447,932 (+13.94%) | View |
| 2023-04-04 08:59 am Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 3,213,586 7.4% | 552,432 (+20.76%) | View |
| 2023-03-07 06:01 am Purchase | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 2,096,258 5.19% | 2,096,258 (New Position) | View |
| 2023-02-14 4:09 pm Sale | 13G | INOZYME PHARMA INC INZY | Venrock Healthcare Capital Partners II L.P. | 3,867,749 9.3% | -197,251 (-4.85%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | INOZYME PHARMA INC INZY | BAKER BROS. ADVISORS LP | 2,168,000 5.1% | 2,168,000 (New Position) | View |